Results 111 to 120 of about 6,307,655 (330)
Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley +1 more source
Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara +10 more
wiley +1 more source
Experiences with designing and managing organic rotation trials [PDF]
This report was presented at the UK Organic Research 2002 Conference. Practical problems encountered in two long-term organic rotation trials at Aberdeen and Elgin are discussed.
Mayer, Claus +4 more
core +1 more source
The impact of leukocyte‐associated RNA retention on platelet RNA‐based cancer detection
Platelets carry RNA signals that may help detect cancer, but platelet samples can also retain RNA from white blood cells. We found that this retained white blood cell signal did not significantly affect machine learning cancer classification, suggesting that the cancer‐related RNA signal in platelets is largely independent of leukocyte‐associated RNA ...
Michał Sieczczyński +12 more
wiley +1 more source
What can we learn from clinical trials of anticonvulsant drugs in epilepsy?
Any physician who intends to utilize the available antiepileptic drugs (AEDs) judiciously, cannot do so without being well versed on their pharmacological properties and the large body of evidence that is continuously accumulating on their relative ...
What Can We Learn From Clinical Trials Of Anticonvulsant Drugs In Epilepsy? +1 more
core +1 more source
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis +20 more
wiley +1 more source
Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer
BACKGROUND: Trimodality therapy (TMT) is a viable option for muscle-invasive localized bladder cancer, providing an alternative to radical cystectomy in properly selected patients.
Parminder Singh +9 more
doaj +1 more source
Outcome measures in vitiligo: A narrative review
Vitiligo disease course being unpredictable in course, it is often difficult to monitor the response to therapy. Though there are many outcome measures, there is a lack of uniformity in reporting these across research papers and clinical trials making it
K.B. Meghana +2 more
doaj +1 more source
Do Baseline P-Values Follow a Uniform Distribution in Randomised Trials?
The theory has been put forward that if a null hypothesis is true, P-values should follow a Uniform distribution. This can be used to check the validity of randomisation.The theory was tested by simulation for two sample t tests for data from a Normal distribution and a Lognormal distribution, for two sample t tests which are not independent, and for ...
openaire +4 more sources
DISTINCTNESS, UNIFORMITY AND STABILITY TRIALS WITH NEW VARIETY OF PLANT (OILSEED RAPE), FINDING OUTLIERS [PDF]
Each new variety reported by breeders to registration, has to be tested with regards to its distinctness, uniformity and stability(DUS). It can only be registered if it differs from other existing varieties in at least one characteristic.
Zawieja, B.
core

